2001•European Journal of PharmacologyRequires access

FR226807: a potent and selective phosphodiesterase type 5 inhibitor

Naomi Hosogai, Kaori Hamada, Masayuki Tomita, Akira Nagashima, Tokiko Takahashi, Toshihiro Sekizawa, Tsuyoshi Mizutani, Yasuharu Urano, Akio Kuroda, Kozo Sawada, Tohru Ozaki, Jiro Seki, Toshio Goto

Open publisher page 19 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 19 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Phosphodiesterase, cGMP-specific phosphodiesterase type 5, Cyclic guanosine monophosphate, Phosphodiesterase 3, Erectile dysfunction, Stimulation, Phosphodiesterase inhibitor, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
FR226807: a potent and selective phosphodiesterase type 5 inhibitor — Research Paper | ScholarLens